Pfizer Inc Stock Analysis

Pfizer Stock Analysis Notes

About 68.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pfizer Inc last dividend was issued on the 23rd of January 2026. The entity had 1054:1000 split on the 17th of November 2020. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people. To find out more about Pfizer Inc contact DVM DVM at 212 733 2323 or learn more at https://www.pfizer.com.

Pfizer Inc Investment Alerts

Pfizer Largest EPS Surprises

View All Earnings Estimates

Pfizer Environmental, Social, and Governance (ESG) Scores

Pfizer Thematic Classifications

Pfizer Stock Institutional Investors

Note, although Pfizer's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 146.52 B.

Pfizer Profitablity

The company has Net Profit Margin of 0.16 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.35 %, which entails that for every 100 dollars of revenue, it generated $0.35 of operating income.

Management Efficiency

Pfizer Inc has Return on Asset of 0.0519 % which means that on every $100 spent on assets, it made $0.0519 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.106 %, implying that it generated $0.106 on every 100 dollars invested. Pfizer's management efficiency ratios could be used to measure how well Pfizer manages its routine affairs as well as how well it operates its assets and liabilities. At present, Pfizer's Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. At present, Pfizer's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 11.9 B, whereas Total Current Assets are forecasted to decline to about 32.8 B.

Technical Drivers

As of the 5th of February, Pfizer holds the Coefficient Of Variation of 720.71, semi deviation of 1.26, and Risk Adjusted Performance of 0.1072. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Please check Pfizer Inc information ratio, as well as the relationship between the value at risk and expected short fall to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 26.78 per share. Given that Pfizer has jensen alpha of 0.1499, we recommend you to check out Pfizer Inc's recent market performance to make sure the company can sustain itself at a future point.

Pfizer Inc Price Movement Analysis

Pfizer Inc Insider Trading Activities

Pfizer Outstanding Bonds

Pfizer Predictive Daily Indicators

Pfizer Corporate Filings

Pfizer Forecast Models

Pfizer's time-series forecasting models are one of many Pfizer's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pfizer Bond Ratings

Pfizer Inc financial ratings play a critical role in determining how much Pfizer have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Pfizer's borrowing costs.

Pfizer Inc Debt to Cash Allocation

Pfizer Inc has (93.1 B) in debt with debt to equity (D/E) ratio of 0.4, which is OK given its current industry classification. Pfizer Inc has a current ratio of 1.56, which is typical for the industry and considered as normal. That said, strategic use of leverage may enable Pfizer to fund expansion initiatives and generate superior returns.

Pfizer Total Assets Over Time

Pfizer Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Pfizer uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Pfizer Debt Ratio

16.0

It looks as if most of the Pfizer's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Pfizer's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Pfizer, which in turn will lower the firm's financial flexibility.

Pfizer Corporate Bonds Issued

Pfizer Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pfizer Inc stock analysis indicators help investors evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pfizer shares will generate the highest return on investment. By understating and applying Pfizer stock analysis, traders can identify Pfizer position entry and exit signals to maximize returns.

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.